RAPT- Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. (RAPT) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. RAPT is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| Dir | 0 | - | - | |
| Other | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sell | 742 | $21.97 | $16,298.77 | -3.7% | -27.0% | +3.5% | |
| Dec 29, 2022 | Ho William75 | Chief Medical Officer | Sell | 5,000 | $18.03 | $90,150.00 | -11.7% | -4.9% | +29.8% | |
| Nov 28, 2022 | Ho William75 | Chief Medical Officer | Sell | 5,000 | $17.87 | $89,350.00 | -10.5% | +66.8% | -18.0% | |
| Nov 2, 2022 | Ho William75 | Chief Medical Officer | Sell | 5,000 | $22.32 | $111,600.00 | -9.5% | +33.6% | -34.7% | |
| Oct 13, 2022 | Ho William75 | Chief Medical Officer | Sell | 2,000 | $21.52 | $43,040.00 | -3.7% | +12.5% | -45.2% | |
| Aug 30, 2022 | Ho William75 | Chief Medical Officer | Sell | 2,500 | $28.13 | $70,325.00 | -4.5% | -34.3% | -27.9% | |
| Jul 11, 2022 | Ho William75 | Chief Medical Officer | Sale+OE | 2,000 | $19.95 | $39,900.00 | -3.7% | +14.0% | +4.2% | |
| May 25, 2022 | Column Group Ii, LP83 | 10% Owner | Buy | 1,900 | $12.45 | $23,664.31 | +0.1% | +93.5% | +47.0% | |
| May 25, 2022 | Column Group Ii, LP83 | 10% Owner | Buy | 1,900 | $12.45 | $23,664.31 | +0.1% | +93.5% | +47.0% | |
| May 24, 2022 | Column Group Ii, LP83 | 10% Owner | Buy | 26,550 | $12.19 | $323,745.09 | +1.1% | +110.2% | +67.4% |